| [1] |
Cramer SC,Finklestein SP,Schaechter JD, et al. Activation of distinct motor cortex regionsduring ipsilateral and contralateral finger movements[J]. J Neurophysiol, 1999, 81(1): 383-387.
|
| [2] |
Jiang Q,Ewing JR,Zhang ZG, et al. Magnetization transfer MRI: application totreatment of middle cerebral artery occlusion in rat[J]. J Magn Reson Imaging, 2001, 13(2): 178-184.
|
| [3] |
Chopp M,Zhang ZG,Jiang Q. Neurogenesis, angiogenesis, and MRI indices offunctional recovery from stroke[J]. Stroke, 2007, 38(2 Suppl): 827-831.
|
| [4] |
Caplan AI. Mesenchymal stem cells[J]. J Orthop Res, 1991, 9(5): 641-650.
|
| [5] |
Caplan AI,Correa D. The MSC: an injury drugstore[J]. Cell Stem Cell, 2011, 9(1): 11-15.
|
| [6] |
Caplan AI. Review: mesenchymal stem cells: cell-basedreconstructive therapy in orthopedics[J]. Tissue Eng, 2005, 11(7-8): 1198-1211.
|
| [7] |
Prockop, DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues[J]. Science, 1997, 276(5309): 71-74.
|
| [8] |
Pittenger MF,Mackay AM,Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells[J]. Science, 1997, 284(5411): 143-147.
|
| [9] |
Sanchez-Ramos J,Song S,Cardozo-Pelaez F, et al. Adult bone marrow stromal cellsdifferentiate into neural cells in vitro[J]. Exp, Neurol, 2000, 164(2): 247-256.
|
| [10] |
Kobune M,Kawano Y,Ito Y, et al. Telomerized human multipotent mesenchymalcells can differentiate into hematopoietic and cobblestone areasupportingcells[J]. Exp Hematol, 2003, 31(8): 715-722.
|
| [11] |
Azizi SA,Stokes D,Augelli BJ, et al. Engraftment and migration of human bonemarrow stromal cells implanted in the brains of albino rats –similarities to astrocyte grafts[J]. Proc Natl Acad Sci U S A, 1998, 95(7): 3908-3913.
|
| [12] |
Brazelton TR,Rossi FM,Keshet GI, et al. From marrow to brain: expression ofneuronal phenotypes in adult mice[J]. Science, 2000, 290(5497): 1775-1779.
|
| [13] |
Woodbury D,Schwarz EJ,Prockop DJ, et al. Adult rat and human bone marrow stromalcells differentiate into neurons[J]. J Neurosci Res, 2000, 61(4): 364-370.
|
| [14] |
Kim S,Honmou O,Kato K, et al. Neural differentiation potential of peripheralblood- and bone-marrow-derived precursor cells[J]. Brain Res, 2006, 1123(1): 27-33.
|
| [15] |
Massengale M,Wagers AJ,Vogel H, et al. Hematopoietic cells maintainhematopoietic fates upon entering the brain[J]. J Exp Med, 2005, 201(10): 1579-1589.
|
| [16] |
Bianco P,Robey PG,Simmons PJ, et al. Mesenchymal stem cells: revisiting history,concepts, and assays[J]. Cell Stem Cell, 2008, 2(4): 313-319.
|
| [17] |
Honma T,Honmou O,Iihoshi S, et al. Intravenous infusion of immortalized humanmesenchymal stem cells protects against injury in a cerebral ischemiamodel in adult rat[J]. Exp Neurol, 2006, 199(1): 56-66.
|
| [18] |
Chen J,Li Y,Wang L, et al. Therapeutic benefit of intravenous administrationof bone marrow stromal cells after cerebral ischemia in rats[J]. Stroke, 2001, 32(4): 1005-1011.
|
| [19] |
Li Y,Chen J,Chen XG, et al. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery[J]. Neurology, 2002, 59(4): 514-523.
|
| [20] |
Horita Y,Honmou O,Harada K, et al. Intravenous administration of glial cell linederivedneurotrophic factor gene-modified human mesenchymal stemcells protects against injury in a cerebral ischemia model in the adultrat[J]. J Neurosci Res, 2006, 84(7): 1495-1504.
|
| [21] |
Iihoshi S,Honmou O,Houkin K, et al. A therapeutic window for intravenousadministration of autologous bone marrow after cerebral ischemia inadult rats[J]. Brain Res, 2004, 1007(1-2): 1-9.
|
| [22] |
Nomura T,Honmou O,Harada K, et al. I.V. infusion of brain-derived neurotrophicfactor gene-modified human mesenchymal stem cells protects againstinjury in a cerebral ischemia model in adult rat[J]. Neuroscience, 2005, 136(1): 161-169.
|
| [23] |
Liu H,Honmou O,Harada K, et al. Neuroprotection by PlGF gene-modified humanmesenchymal stem cells after cerebral ischaemia[J]. Brain, 2006, 129(Pt 10): 2734-2745.
|
| [24] |
Shen LH,Li Y,Chen J, et al. One-year follow-up after bone marrow stromalcell treatment in middle-aged female rats with stroke[J]. Stroke, 2007, 38(7): 2150-2156.
|
| [25] |
Chen X,Li Y,Wang L, et al. Ischemic rat brain extracts induce human marrowstromal cell growth factor production[J]. Neuropathology, 2002, 22(4): 275-279.
|
| [26] |
Chen J,Li Y,Katakowski M, et al. Intravenous bone marrow stromal cell therapyreduces apoptosis and promotes endogenous cell proliferation afterstroke in female rat[J]. J Neurosci Res, 2003, 73(6): 778-786.
|
| [27] |
Kurozumi K,Nakamura K,Tamiya T, et al. BDNF gene-modified mesenchymal stemcells promote functional recovery and reduce infarct size in the ratmiddle cerebral artery occlusion model[J]. Mol Ther, 2004, 9(6): 189-197.
|
| [28] |
Sasaki M,Radtke C,Tan AM, et al. BDNF-hypersecreting human mesenchymalstem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury[J]. J Neurosci, 2009, 29(47): 14932-14941.
|
| [29] |
Toyama K,Honmou O,Harada K, et al. Therapeutic benefits of angiogenetic genemodifiedhuman mesenchymal stem cells after cerebral ischemia[J]. Exp Neurol, 2009, 216(1): 47-55.
|
| [30] |
Onda T,Honmou O,Harada K, et al. Therapeutic benefits by human mesenchymalstem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebralischemia[J]. J Cereb Blood Flow Metab, 2008, 28(2): 329-340.
|
| [31] |
Zhang Z,Chopp M. Vascular endothelial growth factor andangiopoietins in focal cerebral ischemia[J]. Trends Cardiovasc Med, 2002, 12(2): 62-66.
|
| [32] |
Carmeliet P,Collen D. Molecular analysis of blood vesselformation and disease[J]. Am J Physiol, 1997, 273(Pt 2): H2091-H2104.
|
| [33] |
Bates DO,Hillman NJ,Williams B, et al. Regulation of microvascular permeability byvascular endothelial growth factors[J]. J Anat, 2002, 200(6): 581-597.
|
| [34] |
Sasaki M,Lankford KL,Brown RJ, et al. Focal experimental autoimmune encephalomyelitis in the Lewis rat induced by immunization withmyelin oligodendrocyte glycoprotein and intraspinal injection ofvascular endothelial growth factor[J]. Glia, 2010, 58(13): 1523-1531.
|
| [35] |
Suri C,McClain J,Thurston G, et al. Increased vascularization in miceoverexpressing angiopoietin-1[J]. Science, 1998, 282(5388): 468-471.
|
| [36] |
Yancopoulos GD,Davis S,Gale NW, et al. Vascular-specific growth factors andblood vessel formation[J]. Nature, 2000, 407(6801): 242-248.
|
| [37] |
Ward NL,Lamanna JC. The neurovascular unit and itsgrowth factors: coordinated response in the vascular and nervoussystems[J]. Neurol Res, 2004, 26(8): 870-883.
|
| [38] |
Thurston G,Suri C,Smith K, et al. Leakage-resistant bloods in micetransgenically overexpressing angiopoietin-1[J]. Science, 1999, 286(5449): 2511-2514.
|
| [39] |
Sundberg C,Kowanetz M,Brown LF, et al. Stable expression of angiopoietin-1 and othermarkers by cultured pericytes: phenotypic similarities to asubpopulation of cells in maturing vessels during later stages ofangiogenesis in vivo[J]. Lab Invest, 2002, 82(4): 387-401.
|
| [40] |
Baffert F,Le T,Thurston G, et al. Angiopoietin-1 decreases plasma leakage byreducing number and size of endothelial gaps in venules[J]. Am J Physiol Heart Circ Physiol, 2006, 290(1): H107-H118.
|
| [41] |
Carmeliet P. Blood vessels and nerves: common signals, pathways and diseases[J]. Nat Rev Genet, 2003, 4(9): 710-720.
|
| [42] |
Dore-Duffy P,Owen C,Balabanov R, et al. Pericyte migration from the vascular wall inresponse to traumatic brain injury[J]. Microvasc Res, 2000, 60(1): 55-69.
|
| [43] |
Miki Y,Nonoguchi N,Ikeda N, et al. Vascular endothelial growth factor gene-transferred bone marrow stromal cells engineered with a herpes simplex virus type 1 vector can improve neurological deficits and reduced infarction volume in rat brain ischemia[J]. Neurosurgery, 2007, 61(3): 586-594.
|
| [44] |
Crisan M,Yap S,Casteilla L, et al. A perivascular origin for mesenchymal stemcells in multiple human organs[J]. Cell Stem Cell, 2008, 3(3): 301-313.
|
| [45] |
Alvarez-Buylla A,Lim DA. For the long run: maintaininggerminal niches in the adult brain[J]. Neuron, 2004, 41(5): 683-686.
|
| [46] |
Luskin MB,Zigova T,Soteres BJ, et al. Neuronal progenitor cells derived from theanterior subventricular zone of the neonatal rat forebrain continue toproliferate in vitro and express a neuronal phenotype[J]. Mol Cell Neurosci, 1997, 8(5): 351-366.
|
| [47] |
Bang OY,Lee JS,Lee PH, et al. Autologous mesenchymal stem celltransplantation in stroke patients[J]. Ann Neurol, 2005, 57(6): 874- 882.
|
| [48] |
Lee JS,Hong JM,Moon GJ, et al. A long-term follow-up study of intravenousautologous mesenchymal stem cell transplantation in patients withischemic stroke[J]. Stem Cells, 2010, 28(6): 1099-1106.
|
| [49] |
Honmou O,Houkin K,Matsunaga T, et al. Intravenous administration of auto serumexpandedautologous mesenchymal stem cells in stroke[J]. Brain, 2011, 134(Pt16): 1790-1807.
|
| [50] |
Sasaki M,Honmou O,Radtke C, et al. Development of a middle cerebral arteryocclusion model in the nonhuman primate and a safety study of I.V. infusion of human mesenchymal stem cells[J]. PLoS ONE, 2011, 6(10): e26577.
|
| [51] |
Majumdar MK,Thiede MA,Mosca JD, et al. Phenotypic and functional comparison ofcultures of marrow-derived mesenchymal stem cells(MSCs) andstromal cells[J]. J Cell Physiol, 1998, 176(1): 57-66.
|